Bio

Kumaraguru Raja, Ph.D. is a Managing Director, Senior Research Analyst at Roth Capital Partners covering the biotechnology sector. Dr. Raja has over 12 years of sell-side experience covering the biotechnology sector. Prior to Roth, he was Director, Senior Biotech Analyst at Brookline Capital Markets, where he focused on small and microcap companies. He started his equity research career in 2010 as a Senior Associate Analyst on the highly ranked Citi Research biotechnology team. His expertise includes bottom-up scientific and financial analysis on companies across therapeutic areas and across a spectrum of market capitalizations. He focuses on drug development, intellectual property, FDA and EMA regulations, reimbursement coverage and clinical science. He conducted postdoctoral research at Mayo Clinic on the epigenetic causes of cancer and at Los Angeles Biomedical Research Institute on the molecular mechanisms concerning the role of human bone marrow stem cells in normal and leukemic hematopoiesis. He received a doctoral degree from Bowling Green State University and an MBA from University of California, San Diego.